Continuous infusion of pyridoxalated hemoglobin polyoxyethylene conjugate in hyperdynamic septic sheep

Shock

Volumn 10, Issue 1, 1998, Pages 69-76

  Bone, Hans G ^b   Fischer, Stefanie R ^a   Schenarts, Paul J ^a   McGuire, Roy ^a   Traber, Lillian D ^a   Traber, Daniel L ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MACROGOL DERIVATIVE; PYRIDOXALATED HEMOGLOBIN POLYETHYLENE GLYCOL CONJUGATE; PYRIDOXALATED-HEMOGLOBIN-POLYETHYLENE GLYCOL CONJUGATE;

ANIMAL; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; GRAM NEGATIVE INFECTION; INTRAARTERIAL DRUG ADMINISTRATION; LUNG; MICROBIOLOGY; MORTALITY; OXYGEN CONSUMPTION; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; SEPSIS; SHEEP;

ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBINS; INFUSIONS, INTRA-ARTERIAL; LUNG; OXYGEN CONSUMPTION; POLYETHYLENE GLYCOLS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REGIONAL BLOOD FLOW; SEPSIS; SHEEP;

EID: 0032112066     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199807000-00012     Document Type: Article

References (32)

1. Evans T, Carpenter A, Kinderman H, Cohen J: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77-81, 1993.
2. Meyer J, Lentz CW, Stothert JC, Traber LD, Herndon DN, Traber DL: Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 22:306-312, 1994.
3. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557-1558, 1991.
4. Alayash AI, Cashon RE: Reactions of nitric oxide and hydrogen peroxide with hemoglobin-based blood substitutes. Ann NY Acad Sci 738:378-381, 1994.
5. Katsuyama SS, Cole DJ, Drummond JC, Bradley K: Nitric oxide mediates the hypertensive response to a modified hemoglobin solution (DCLHb) in rats. Artif Cell Blood Sub 22:1-7, 1994.
6. Aranow JS, Wang H, Zhuang J, Fink MP: Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock. Crit Care Med 24:807-814, 1996.
7. Mourelatos MG, Enzer N, Ferguson JL, Rypins EB, Burhop KE, Law WR: The effects of diaspirin cross-linked hemoglobin in sepsis. Shock 5:141-148, 1996.
8. Griffiths E, Cortes A, Gilbert N, Stevenson P, MacDonald S, Pepper D: Haemoglobin-based blood substitutes and sepsis. Lancet 345:158-160, 1995.
9. Roth RI: Hemoglobin enhances the binding of bacterial endotoxin to human endothelial cells. Thromb Haemostasis 76 :258-262, 1996.
10. Booke M, Meyer J, Lingnau W, Hinder F, Traber LD, Traber DL: Use of nitric oxide inhibitors in animal models of sepsis. New Horizons 3:123-138, 1995.
11. Dietz NM, Joyner MJ, Warner MA: Blood substitutes: Fluids, drugs, or miracle solutions? Anesth Analg 82:390-405, 1996.
12. Jones JA: Red blood cell substitutes: Current status. Br J Anaesthesiol 74:697-703, 1995.
13. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS: A role for endothelin and nitric oxide in the presser response to diaspirin cross-linked hemoglobin. J Lab Clin Med 122:301-308, 1993.
14. Gulati A, Sharma AC, Singh G: Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 24:137-147, 1996.
15. Kida Y, Maeda M, Iwata S, Iwashita Y, Goto K, Nishi K: Effects of pyridoxalated hemoglobin polyoxyethylene conjugate and other hemoglobin-related substances on arterial blood pressure in anesthetized and conscious rats. Artif Organs 19:117-128, 1995.
16. Crowley JP, Metzger J, Gray A, Pivacek LE, Cassidy G, Valeri CR: Infusion of stroma-free cross-linked hemoglobin during acute Gram-negative bacteremia. Circ Shock 41:144-149, 1993.
17. Assreuy J, Cunha FQ, Liew FY, Moncada S: Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 108:833-837, 1993.
18. Nussler AK, Billiar TR: Inflammation, immunoregulation and inducible nitric oxide synthase. J Leukocyte Biol 54:171-178, 1993.
19. Hughes GS, Antal EJ, Locker PK, Francom SF, Adams WJ, Jacobs EE: Physiology and pharmocokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 24:756-764, 1996.
20. Lee R, Neya K, Svizzero TA, Vlahakes GJ: Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 79:236-242, 1995.
21. Booke M, Hinder F, McGuire R, Traber LD, Traber DL: Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: Effects on regional blood flow. Shock 5:362-370, 1996.
22. Heyland DK, Cook DJ, King D, Kernermann P, Brun-Buisson C: Maximizing oxygen delivery in critically ill patients: A methodologic appraisal of the evidence. Crit Care Med 24:517-524, 1996.
23. Hayes MA, Timmis AL, Yau EH, Palazza M, Watson D, Hinds CJ: Oxygen transport patterns in patients with sepsis syndrome or septic shock: Influence of treatment and relationship to outcome. Crit Care Med 25:926-936, 1997.
24. Lingnau W, McGuire R, Dehring DJ, Traber LD, Traber DL: Changes in regional hemodynamics after nitric oxide inhibition during ovine bacteremia. Am J Physiol 270:R207-R216:1996.
25. Hess JR, Macdonald VW, Brinkley WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 74:1769-1778, 1993.
26. Otterbein L, Sylvester SL, Choi AMK: Hemoglobin provides protection against lethal endotoxemia in rats: The role of heme oxygenase-1. Am J Respir Cell Mol Biol 13:595-601, 1995.
27. Malchesky PS, Takahashi T, Iwasaki K, Harasaki H, Nose Y: Conjugated human hemoglobin as a physiological oxygen carrier-pyridoxalated hemoglobin polyoxyethylene conjugate (PHP). Int J Artif Organs 13:442-450, 1990.
28. Rudis MA, Basha MA, Zarowitz BJ: Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 24:525-537, 1996.
29. Yoshida M, Roth RI, Levin J: The effect of cell-free hemoglobin on intravascular clearance and cellular, plasma, and organ distribution of bacterial endotoxin in rabbits. J Lab Clin Med 126:151-160, 1995.
30. Roth RI, Kaca W, Levin J: Hemoglobin: A newly recognized binding protein for bacterial endotoxins (LPS). Prog Clin Biol Res 388:161-172, 1994.
31. Langermans JA, van Vuren-van der Hulst ME, Bleeker WK: Safety evaluation of a polymerized hemoglobin solution in a murine infection model. J Lab Clin Med 127:428-434, 1996.
32. Litwin MS, Walter CW, Ejarque P, Reynolds ES: Synergistic toxicity of Gram-negative bacteria and free colloidal hemoglobin. Ann Surg 157:485-493, 1963.